Generic Ribavirin
	Generic Ribavirin
	Generic Ribavirin
	Generic Ribavirin
	Generic Ribavirin
	Rebetol
	Rebetol
	Rebetol
	Rebetol (also known as Copegus)
	Rebetol (also known as Copegus)
	Rebetol (also known as Copegus)
	Rebetol (also known as Copegus)

Rebetol Solution

* RIBAVIRIN

Rebetol Drug Information

The drug contains a synthetic nucleoside analogue and is used to treat chronic hepatitis C. It can be administered in combination with interferon alfa products such as A or Peg-Intron. It is important to take the drug with food. For genotype 1 patients, the treatment lasts 48 weeks. Rebetol should be administered with caution in patients that already have a cardiac disease.

Rebetol Drug Dosage

The drug should not be opened, broken, or crushed in any manner. The daily dosage of Ribavirin can be varied from 15 mg/kg to 1200 mg/day. The dosage of the generic drug should be appointed individually by the physician following a thorough examination. The drug is available in the dosage of 200 mg. At North Meds customers can choose the cheap Rebetol which is available as a generic drug in the dosage of 200 mg, and also as a brand drug in the dosages of 200 mg and 400 mg. Assorted quantities can be ordered online as discount Rebetol.

Side Effects and Precautions for Rebetol

Severe side effects for patients who buy Rebetol include hemolytic anemia, usually 1 or 2 weeks following the start of the treatment. With patients taking Ribavirin, cardiac and pulmonary reactions associated with anemia, eye disorders like retinal detachment, or hearing disorders may occur. Patients developing ocular symptoms should have their eyes examined. Common side effects include chills, fatigue, anxiety, depression, suicidal ideation, nausea, rashes, anemia, pyrexia, diarrhea, weight loss, alopecia, myalgia, unspecified pain, leucopenia, dry skin. In the event of any of these symptoms your physician should be consulted immediately. Patients with ophthalmologic disorders (such as diabetic or hypertensive retinopathy) should be examined during combination therapy. With pregnant women, the drug may cause birth defects or death of the unborn child. Prior to starting therapy a report of negative pregnancy should be available.

* All trademarks and registered trademarks are the property of their respective owners.